N-acetylcholinesterase-induced apoptosis in alzheimer's disease

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Toiber, Debra ^a   Berson, Amit ^a   Greenberg, David ^a   Melamed Book, Naomi ^a   Diamant, Sophia ^a   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CALCIUM; CASPASE 3; CHOLINESTERASE INHIBITOR; FASCICULIN; FLUORESCENT DYE; GLYCOGEN SYNTHASE KINASE 3; PROTEIN BCL 2; TAU PROTEIN; CASPASE; CHOLINERGIC RECEPTOR;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL STRESS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; SUPPRESSOR CELL; TISSUE CULTURE; UPREGULATION; BIOLOGICAL MODEL; BRAIN; CELL MEMBRANE; ENZYMOLOGY; GENETIC VARIABILITY; GENETICS; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; APOPTOSIS; BRAIN; CASPASES; CELL MEMBRANE; GENETIC VARIATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MODELS, BIOLOGICAL; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CHOLINERGIC; TAU PROTEINS;

EID: 52149104322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003108     Document Type: Article

References (46)

1. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofi-brillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42: 631-639.
2. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, et al. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239.
3. Mesulam M (2004) The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn Mem 11: 43-49.
4. Nordberg A (2006) Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease. Alzheimer Dis Assoc Disord 20: S12-18.
5. Recanatini M, Valenti P (2004) Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. Curr Pharm Des 10: 3157-3166.
6. Huang HC, Klein PS (2006) Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease. Curr Drug Targets 7: 1389-1397.
7. Bhat RV, Budd Haeberlein SL, Avila J (2004) Glycogen synthase kinase 3: a drug target for CNS therapies. J Neurochem 89: 1313-1317.
8. Landwehrmeyer B, Probst A, Palacios JM, Mengod G (1993) Expression of acetylcholinesterase messenger RNA in human brain: an in situ hybridization study. Neuroscience 57: 615-634.
9. Park SE, Kim ND, Yoo YH (2004) Acetylcholinesterase plays a pivotal role in apoptosome formation. Cancer Res 64: 2652-2655.
10. Zhu H, Gao W, Jiang H, Jin QH, Shi YF, et al. (2007) Regulation of acetylcholinesterase expression by calcium signaling during calcium ionophore A23187- and thapsigargin-induced apoptosis. Int J Bioehem Cell Biol 39: 93-108.
11. Dickson DW (2004) Apoptotic mechanisms in Alzheimer neurofi-brillary degeneration: cause or effect? J Clin Invest 114: 23-27.
12. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1: 120-129.
13. Meshorer E, Soreq H (2006) Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci 29: 216-224.
14. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116: 25-219.
15. Massoulie J (2002) The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11: 130-143.
16. Huang CJ, Haataja L, Gurlo T, Butler AE, Wu X, et al. (2007) Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am J Physiol Endocrinol Metab 293: E1656-1662.
17. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, et al. (2004) Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24: 9993-10002.
18. Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinaze-3. Trends Biochem Sci 29: 95-102.
19. Russ C, Lovestone S, Powell JF (2001) Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Mol Psychiatry 6: 320-324.
20. Ichtchenko K, Nguyen T, Sudhof TC (1996) Structures, alternative splicing, and neurexin binding of multiple neuroligins, J Biol Chem 271: 2676-2682.
21. Peng HB, Xie H, Rossi SG, Rotundo RL (1999) Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145: 911-921.
22. Meshorer E, Tolher D, Zurel D, Sahly I, Dori A, et al. (2004) Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products. J Biol Chem 279: 29740-29751.
23. Higgins MK, McMahon HT (2002) Snap-shots of clathrin-mediated endocytosis. Trends Biochem Sci 27: 257-263.
24. Bourne Y, Kolb HC, Radic Z, Sharpless KB, Taylor P, et al. (2004) Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proc Natl Acad Sci U S A 101: 1449-1454.
25. Mc IR, Koelle GB (1959) Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission. J Pharmacol Exp Ther 126: 9-20.
26. Kaufer D, Friedman A, Seidman S, Soreq H (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393: 373-377.
27. Meshorer E, Erb C, Gazit R, Pavlovsky L, Kaufer D, et al. (2002) Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 295: 508-512.
28. Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A 87: 2466-2470.
29. Kaufer D, Ogle WO, Pincus ZS, Clark KL, Nicholas AC, et al. (2004) Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci 7: 947-953.
30. Soreq H, Seidman S (2001) Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2: 294-302.
31. Killiany RJ, Gomez-Isla T, Moss M, Kildnis R, Sandor T, et al. (2000) Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 47: 430-439.
32. Sklan EH, Lowenthal A, Korner M, Ritov Y, Landers DM, et al. (2004) Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study. Proc Natl Acad Sci U S A 101: 5512-5517.
33. Eggers C, Herholz K, Kalbe E, Heiss WD (2006) Cotrical acetylcholine esterase activity and ApoE4-genotype in Alzheimer disease. Neurosci Lett 408: 46-50.
34. Nguyen HN, Hwang DY, Kim YK, Yoon DY, Kim JH, et al. (2005) Mutant presenilin 2 increases acetylcholinesterase activity in neuronal cells. Arch Pharm Res 28: 1073-1078.
35. Carroll RT, Lust MR, Emmerling MR (1999) Beta-amyloid levels predict cholinesterase activity in human cerebrospinal fluid. Neuroreport 10: 127-130.
36. Hu W, Gray NW, Brimijoin S (2003) Amyloid-beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation. J Neurochem 86: 470-478.
37. Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH (1997) The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem 69: 1177-1184.
38. Deng K, Li W, Guan Z, Zhou JM, Wang Y, et al. (2006) Acetylcholinesterase expression mediated by c-Jun-NH2-terminal kinase pathway during anticancer drug-induced apoptosis. Oncogene 25: 7070-7077.
39. Kehat R, Zemel E, Cuenca N, Evron T, Toiber D, et al. (2007) A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress. Invest Ophthalmol Vis Sci 48: 1290-1297.
40. Toiber D, Soreq H (2005) Cellular stress reactions as putative cholinergie links in Alzheimer's disease. Neurochem Res 30: 909-919.
41. de la Rosa EJ, de Pablo F (2000) Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci 23: 454-458.
42. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, et al. (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253: 872-879.
43. Millard CB, Kryger G, Ordentlich A, Greenblatt HM, Harel M, et al. (1999) Crystal structures of aged phosphonylated acetylchotinesterase: nerve agent reaction products at the atomic level. Biochemistry 38: 7032-7039.
44. Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, et al. (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc Natl Acad Sci U S A 104: 3591-3596.
45. Berson A, Knobloch M, Hanan, M, Diamant S, Sharoni M, et al. (2008) Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology. Brain 131: 109-119.
46. Ben-Ari S, Toiber D, Sas AS, Soreq H, Ben-Shaul Y (2006) Modulated splicing-associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants. J Neurochem 97 Suppl 1: 24-34.